// App-Quantinova.ai

: Early Cytopenias and Infections Following Chimeric Antigen Receptor T-Cell Therapy: A Single Center Experience

Researchers

Presenter

  • Mary McGann

Principal Investigators

  • Arash Velayati

  • Kiera Roubal

  • Katelynn Granger

  • Hamza Hashmi

Medical Centers

  • Medical university of south carolina, Charleston, SC

  • Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Cytokine release syndrome

  • Hematological malignancies

  • Hypogammaglobulinaemia

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Multiple Myeloma

  • Lymphomas

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

  • Cytokine

  • Granulocyte colony-stimulating factor

  • Immunoglobulin G

  • Twist-related protein 1

Drug/Treatment

  • Filgrastim

  • IVIG

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved